DRKS00030743尚未招募Unknown
Probing the efficacy of neurostimulation on reading and reading-related measures in adults with developmental dyslexia - ReDyslexia O4
Professur für Kognitive und Klinische Neurowissenschaften, Fakultät Psychologie, Technische Universität Dresden0 个研究点目标入组 85 人开始时间: 2023年3月2日最近更新:
试验速览
- 阶段
- Unknown
- 状态
- 尚未招募
- 发起方
- 入组人数
- 85
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
- 分配方式
- Randomized controlled study
- 盲法
- Blinded (masking used)
入排标准
- 年龄范围
- 18 Years 至 45 Years（—）
- 性别
- All
入选标准
- •We plan to include 85 individuals (65 individuals diagnosed with DD and 20 controls) for this study.
- •The inclusion criteria for the participants with DD will be: (1) right-handed German speakers participants of both genders, diagnosed with DD according to participants’ self-report, lifelong symptoms from childhood; (2) reading accuracy and/or speed, as assessed by measures commonly used for diagnosis of DD in Germany (i.e., LGVT), of at least 1.5 standard deviations (SD) below the mean for typically-reading adults; (3) non-verbal Intelligence Quotient (nvIQ86) higher or equal to 85 (IQ = 85); (4) normal hearing and normal or corrected-to-normal vision.
- •For the control group, the inclusion criteria will be: (1) right-handed German speakers participants of both genders without any neurological disorders; (2) non-verbal Intelligence Quotient (nvIQ86) higher or equal to 85 (IQ = 85); (3) normal hearing and normal or corrected-to-normal vision.
排除标准
- •The exclusion criteria for the participants with DD involve the following: (1) the presence of other primary psychiatric/neurological diagnosis (e.g., depression, anxiety, autism, ADHD, but not dyscalculia); (2) a personal history of neurological/medical/genetic diseases; (3) ongoing drug treatment influencing brain function; (4) a personal history or first-degree relatives’ history of epilepsy; (5) incompatibility with tDCS; (6) incompatibility with MRI.
- •The exclusion criteria for the healthy participants involve the following: (1) the presence of any psychiatric/neurological diagnosis (e.g., depression, anxiety, autism, ADHD); (2) a personal history of neurological/medical/genetic diseases; (3) ongoing drug treatment influencing brain function; (4) a personal history or first-degree relatives’ history of epilepsy; (5) incompatibility with MRI.
研究者
相似试验
已完成
不适用
on-pharmacological techniques for cognitive improvement in schizophreniaSchizophreniaRBR-69g952niversidade Federal de São Paulo
已完成
2 期
The effectiveness of interactive neurostimulation in the management of acute postoperative pain following a total hip replacement – a pilot randomized controlled trialTotal hip replacementPhysical Medicine / Rehabilitation - PhysiotherapyACTRN12609000776202Catherine Norman20
招募中
不适用
The effect of tDCS brain stimulation on memory improvement in schizophrenic patientsSchizophreniaIRCT20160528028118N2Tabriz University of Medical Sciences60
已完成
不适用
Study of the Safety and Efficacy of Neurostimulation of the Cholinergic Anti-Inflammatory Pathway Using a Vagal Nerve Stimulation Device in Patients with Active Refractory Crohn*s Disease10017969Crohn's DiseaseInflammatory Bowel DiseaseNL-OMON44525SetPoint Medical Corporation3
已完成
不适用
Randomized controlled trial of neurostimulation treatment for apathy in schizophreniaapathylistlessnesspsychosis10039628NL-OMON41353niversitair Medisch Centrum Groningen150